Immunoclassification of Psoriasis: a Strategy for Precision Medicine

NCT05503875 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Immunoclassification
Psoriasis

Interventions

BIOLOGICAL: adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University